Kenvue's profitability, with gross margins above 58% and EBITDA margins over 23%, provides resilience against legal and ...

Kenvue shares rose 6% in premarket trading on Tuesday, set to rebound from a record low hit in the previous session as U.S.

Shares may be rising because investors expected the White House to announce stricter regulations on the medication, Citi ...

President Donald Trump created a potentially existential crisis for Tylenol maker Kenvue Inc. with just three words about the ...

Independent, sound science clearly shows that taking acetaminophen does not cause autism,” a Kenvue spokesperson told ...

Kenvue stock rallied on Tuesday off a record low, after a White House press conference didn’t offer fresh evidence that could ...

Economists saw “limited” risk to the pharmaceutical firm’s stock, despite some expected impact on Tylenol consumption.

President Donald Trump is set to speak today on how Tylenol may be linked to autism. Here's when, who makes Tylenol, and ...

The White House is reportedly planning to link Tylenol use during pregnancy to autism. The news pushed Kenvue stock down 8%.

Earlier this week, the Trump administration publicly warned of a possible link between prenatal Tylenol use and autism, ...

Tylenol, Kenvue’s biggest product, has been sold over-the-counter in the United States since the 1960s and makes up about 10% of group sales. Rothschild estimated that sales to expectant mothers ...